# Clinical trials recruiting in Pennsylvania: 3,393 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 3,393 trials recruiting or not yet recruiting with a site in Pennsylvania, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Pennsylvania: 3,393 rows for $113.93, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 54 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/pennsylvania

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 3,393
- Recruiting or not yet: 3,393
- Read on: November 19, 2026

## Trials

The 25 newest of 3,393, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944053 | Group Antenatal Healthcare, Education, and Recovery | Thomas Jefferson University | Not applicable | Recruiting | Opioid Use Disorder, Pregnancy | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944053) |
| November 17, 2026 | NCT07942077 | FLASH Biomarker Study | Abramson Cancer Center at Penn Medicine | Observational | Not yet recruiting | Head and Neck Cancer | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942077) |
| November 17, 2026 | NCT07940673 | Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game | University of Pittsburgh | Not applicable | Not yet recruiting | Alzheimer's Disease and Related Dementias, Advance Care Planning | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940673) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 16, 2026 | NCT07937696 | A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Colorectal Carcinoma, EPCAM Lynch Syndrome, Lynch Syndrome, MLH1 Lynch Syndrome, MSH2 Lynch Syndrome, MSH6 Lynch... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937696) |
| November 13, 2026 | NCT07937033 | Bridging Rural Inclusion for Dietary Guidance and Education (BRIDGE) Study | Penn State University | Observational | Not yet recruiting | Eating Behaviors | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937033) |
| November 13, 2026 | NCT07934511 | Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Stroke | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934511) |
| November 12, 2026 | NCT07934303 | Study of NBIB-223 Gene Therapy in Friedreich's Ataxia (FACET) | Neurocrine Biosciences | Phase 1 | Not yet recruiting | Friedreich's Ataxia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934303) |
| November 12, 2026 | NCT07933406 | Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Alcohol Consumption, Alcohol Use Disorder (AUD), Substance Use (Drugs, Alcohol), Substance Use Disorder (SUD)... | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933406) |
| November 12, 2026 | NCT07932808 | Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma | Sponsor not shown (see the record) | Phase 2 | Recruiting | Neuroblastoma | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932808) |
| November 12, 2026 | NCT07932405 | Adaptive Radiotherapy for Patients With GBM | Abramson Cancer Center at Penn Medicine | Not applicable | Not yet recruiting | Glioblastoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932405) |
| November 12, 2026 | NCT07932106 | Identifying Mediators of Exercise-induced Tumor Microenvironment Remodeling to Enhance Primary Chemotherapy Response (IMPROVE-Ovarian) | University of Pittsburgh | Not applicable | Not yet recruiting | High Grade Serous Ovarian, Ovarian Adenocarcinoma, Ovarian Cancer, Serous Adenocarcinoma of Ovary, Ovarian Cancer (OvCa) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932106) |
| November 12, 2026 | NCT07932067 | Circulating Tumor DNA-Informed Adjuvant Therapy for Intermediate-Risk Head and Neck Cancer | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Head and Neck Cancer | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932067) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 10, 2026 | NCT07928648 | Low Intensity Focused Ultrasound in Cocaine Use Disorder | University of Pennsylvania | Phase 1 | Not yet recruiting | Cocaine Use Disorder (CUD) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928648) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927686 | SCREEN Yourself for Cancer | Milton S. Hershey Medical Center | Not applicable | Not yet recruiting | Colorectal Cancer Screening, Cervical Cancer Screening | 852 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927686) |
| November 10, 2026 | NCT07927673 | Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV | Montefiore Medical Center | Not applicable | Not yet recruiting | Substance Use Disorder (SUD), HIV (Human Immunodeficiency Virus), Viral Suppression of HIV Infection | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927673) |
| November 10, 2026 | NCT07927413 | Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients | Corza Medical GmbH | Observational | Recruiting | Cerebrospinal Fluid (CSF) Leak, Psuedomeningocele | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927413) |
| November 9, 2026 | NCT07926594 | Effectiveness Study of TRYPTYR in Dry Eye Disease | Scott & Christie and Associates, PC | Observational | Recruiting | Dry Eye Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926594) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07923370 | Facial Expression Awareness Training to Understand and Recognize Emotions | Children's Hospital of Philadelphia | Not applicable | Recruiting | Survivors of Pediatric Brain Tumors, Pediatric Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923370) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Pennsylvania | Philadelphia | 335 |
| Children's Hospital of Philadelphia | Philadelphia | 286 |
| UPMC Hillman Cancer Center | Pittsburgh | 175 |
| University of Pittsburgh | Pittsburgh | 154 |
| University of Pittsburgh Medical Center | Pittsburgh | 138 |
| Thomas Jefferson University Hospital | Philadelphia | 119 |
| Fox Chase Cancer Center | Philadelphia | 111 |
| Geisinger Medical Center | Danville | 103 |
| Thomas Jefferson University | Philadelphia | 94 |
| Hospital of the University of Pennsylvania | Philadelphia | 87 |
| Geisinger Wyoming Valley/Henry Cancer Center | Wilkes-Barre | 69 |
| Allegheny General Hospital | Pittsburgh | 69 |
| Lehigh Valley Hospital-Cedar Crest | Allentown | 67 |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | 57 |
| Geisinger Medical Oncology-Lewisburg | Lewisburg | 50 |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | 50 |
| Lehigh Valley Hospital - Muhlenberg | Bethlehem | 47 |
| Temple University Hospital | Philadelphia | 45 |
| Penn State Milton S Hershey Medical Center | Hershey | 44 |
| Pocono Medical Center | East Stroudsburg | 43 |
| UPMC Hillman Cancer Center Erie | Erie | 40 |
| Temple University | Philadelphia | 40 |
| Christiana Care Health System-Concord Health Center | Chadds Ford | 40 |
| Lehigh Valley Hospital-Hazleton | Hazleton | 40 |
| Asplundh Cancer Pavilion | Willow Grove | 37 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 56 |
| Phase 1 | 247 |
| Phase 1/2 | 240 |
| Phase 2 | 564 |
| Phase 2/3 | 81 |
| Phase 3 | 686 |
| Phase 4 | 107 |
| Not applicable | 828 |
| Observational | 584 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 115 |
| Carcinoma, Non-Small-Cell Lung | 114 |
| Breast Neoplasms | 101 |
| Neoplasm Metastasis | 72 |
| Colorectal Neoplasms | 72 |
| Prostatic Neoplasms | 67 |
| Ovarian Neoplasms | 66 |
| Lung Neoplasms | 66 |
| Depression | 54 |
| Obesity | 53 |
| Melanoma | 51 |
| Endometrial Neoplasms | 51 |
| Squamous Cell Carcinoma of Head and Neck | 47 |
| Heart Failure | 46 |
| Leukemia, Myeloid, Acute | 45 |
| Pancreatic Neoplasms | 43 |
| Recurrence | 43 |
| Stroke | 42 |
| Cardiovascular Diseases | 39 |
| Pulmonary Disease, Chronic Obstructive | 38 |
| Diabetes Mellitus, Type 2 | 37 |
| Overweight | 35 |
| Carcinoma, Renal Cell | 32 |
| Stomach Neoplasms | 32 |
| Urinary Bladder Neoplasms | 31 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Pennsylvania | 182 |
| University of Pittsburgh | 145 |
| National Cancer Institute (NCI) | 87 |
| Children's Hospital of Philadelphia | 78 |
| Abramson Cancer Center at Penn Medicine | 70 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 68 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 55 |
| Thomas Jefferson University | 49 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 48 |
| Milton S. Hershey Medical Center | 46 |
| Penn State University | 42 |
| VA Office of Research and Development | 39 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 36 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 31 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 30 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 29 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 29 |
| Children's Oncology Group | 27 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 25 |
| SWOG Cancer Research Network | 24 |
| Fox Chase Cancer Center | 24 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 24 |
| Alliance for Clinical Trials in Oncology | 23 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 22 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 22 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Pennsylvania

- [Graphic design firms in Pennsylvania, United States](https://specstream.ai/data/businesses/graphic-design-firms/pennsylvania-united-states)
- [Naturopathic clinics in Pennsylvania, United States](https://specstream.ai/data/businesses/naturopathic-clinics/pennsylvania-united-states)
- [Shipping and delivery companies in Pennsylvania, United States](https://specstream.ai/data/businesses/shipping-and-delivery-companies/pennsylvania-united-states)
- [Automation companies in Pennsylvania, United States](https://specstream.ai/data/businesses/automation-companies/pennsylvania-united-states)
- [Diagnostic imaging centers in Pennsylvania, United States](https://specstream.ai/data/businesses/diagnostic-imaging-centers/pennsylvania-united-states)
- [Interior design firms in Pennsylvania, United States](https://specstream.ai/data/businesses/interior-design-firms/pennsylvania-united-states)
